Medicare, greater transparency
Trump's Administration Aims for 'Greater Transparency' in Drug Price Negotiations
The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following criticism from the pharmaceutical industry for the Biden-era law.
Newsweek on MSN4d
Donald Trump's Medicare Executive Order ExplainedDonald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.
18hon MSN
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Medicare is a U.S. government insurance program for people over 65 years old or younger people with certain disabilities. It covers a range of healthcare services, including doctor visits ...
An order by President Donald Trump freezes potentially trillions of dollars of grants and loans, but Congressional leaders ...
In a contentious confirmation hearing to be the nation’s top health official, Robert F. Kennedy Jr. struggled to answer questions about how he would reform Medicaid or Medicare, the government health ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
The nonpartisan Congressional Budget Office released its latest 10-year budget outlook, which projected the U.S. is on track ...
The Mirror US on MSN1d
Medicaid portals 'down': What’s the difference between Medicaid and Medicare and why it matters in this crisisU.S. Senator Ron Wyden, who has long been an advocate for healthcare access, condemned the apparent shutdown of Medicaid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback